Holen Sie sich die Stockscreener-App
9.44
2.58%
-0.25
Handel nachbörslich:
11.00
1.56
+16.53%
Schlusskurs vom Vortag:
$9.69
Offen:
$9.49
24-Stunden-Volumen:
15,295
Relative Volume:
0.11
Marktkapitalisierung:
$7.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.93M
KGV:
-0.0355
EPS:
-266.137
Netto-Cashflow:
$-15.87M
1W Leistung:
+8.26%
1M Leistung:
+24.70%
6M Leistung:
-90.34%
1J Leistung:
-98.71%
1-Tages-Spanne:
$9.3932
$9.90
1-Wochen-Bereich:
$8.78
$10.38
52-Wochen-Spanne:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Firmenname
Transcode Therapeutics Inc
Sektor
Branche
Telefon
857-301-6857
Adresse
6 LIBERTY SQUARE, BOSTON
Vergleichen Sie RNAZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
9.44 | 7.27M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten
What drives TransCode Therapeutics Inc. stock priceTurbocharged investment results - jammulinksnews.com
TransCode Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com
What analysts say about TransCode Therapeutics Inc. stockFree Investment Risk Control - jammulinksnews.com
Is TransCode Therapeutics Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
TransCode Therapeutics (NASDAQ:RNAZ) Upgraded at Wall Street Zen - Defense World
Will TransCode Therapeutics Inc. stock benefit from interest rate changesPotential Rocket List - Newser
What analysts say about CleanCore Solutions Inc. stock outlookSecure Your Capital Strategy - Newser
Is SS Innovations International Inc. stock a good hedge against inflationGroup Only Stock Signals - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
RNAZ SEC FilingsTranscode Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What makes TransCode Therapeutics Inc. stock price move sharplyFree Group Entry - Newser
How TransCode Therapeutics Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
When (RNAZ) Moves Investors should Listen - news.stocktradersdaily.com
TransCode Therapeutics (NASDAQ:RNAZ) Trading 14.9% Higher – Should You Buy? - Defense World
STP(showtime potocol) News and UpdatesFast and Easy Profits with $100 - Newser
(RNAZ) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Head-To-Head Analysis: TransCode Therapeutics (NASDAQ:RNAZ) vs. Silence Therapeutics (NASDAQ:SLN) - Defense World
(RNAZ) Proactive Strategies - news.stocktradersdaily.com
TransCode Therapeutics (NASDAQ:RNAZ) Trading 4.7% Higher – Here’s Why - Defense World
TransCode Therapeutics Announces 2025 Annual Meeting Date - TipRanks
(RNAZ) Investment Analysis - news.stocktradersdaily.com
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
(RNAZ) On The My Stocks Page - news.stocktradersdaily.com
Transcode Therapeutics Appoints Dr. Phillip D. Zamore To Science Advisory Board - marketscreener.com
TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - citybiz
TransCode Therapeutics appoints RNA expert to advisory board - Investing.com
TransCode Therapeutics appoints RNA expert to advisory board By Investing.com - Investing.com Nigeria
TransCode Therapeutics (NASDAQ:RNAZ) Cut to “Sell” at Wall Street Zen - Defense World
Certain Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail
Transcode Therapeutics (RNAZ) Trading Halted Pending News Announ - GuruFocus
Transcode Therapeutics (RNAZ) Trading Halted Pending News Announcement | RNAZ Stock News - GuruFocus
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):